23.03.2017 • NewsDede WillamsBASFDicamba

BASF Inaugurates Texas Dicamba Plant

(c) Derek Dammanni/Stockphoto
(c) Derek Dammanni/Stockphoto

BASF has inaugurated its new $270 million world-scale production complex for dicamba, the active ingredient in its Engenia herbicide, at its Beaumont, Texas, site. The German group received permission to produce the chemical from the US Environmental Protection Agency (EPA) in December of last year.

The Ludwigshafen-based chemical giant has invested more than $370 million over the past five years to expand its overall manufacturing capability at Beaumont, and Markus Heldt, president of the Crop Protection division, said the latest investment – for which capacity was not quantified – is the largest ever, expanding output capability at the Texas site by 50%.

In addition to Beaumont, BASF has invested more than $290 million in eight other agricultural products facilities, along with other facilities that support its agricultural business across North America, said Paul Rea, senior vice president, Crop Protection North America. The latest expansion reflects the group’s commitment to North America and to driving strategic investments to match customers’ expectations, executives said.

With more than 50 years of technical expertise with dicamba, BASF said it continues to advance the molecule’s performance, effectiveness and on-target application. Engenia features a completely new formulated dicamba molecule, known as BAPMA salt, which is designed specifically for dicamba-tolerant soybeans and cotton.

The US launch kicks off BASF’s global introduction of Engenia. In the “near future,” the group said, it will offer its new herbicide solution to markets in Latin America.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.